Astero Erado Inc
Publicly observedCollege Station, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | College Station | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Astero Erado Inc | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | Z3JWEMNYNRT9 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant11 Aug 2026Publicly observed
NIH SBIR/STTR award: Severe Autoantibody-Mediated Autoimmune Disease: A New Treatment Approach
USD 306,449.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jan 2023Publicly observed
NIH SBIR/STTR award: Novel approaches for the treatment of autoimmune disease
USD 1,018,916.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jan 2023Publicly observed
NIH SBIR/STTR award: Novel approaches for the treatment of autoimmune disease
USD 1,019,657.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant11 Mar 2022Publicly observed
NIH SBIR/STTR award: Depleting autoantibodies for the treatment of autoimmunity
USD 863,199.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.